BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7944198)

  • 21. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival of limb allografts after weaning of cyclosporine: possible role of microchimerism.
    Durlik M; Lukomska B; Namysłowski A; Janczewska S; Cybulska E; Olszewski WL
    Transplant Proc; 1997; 29(1-2):1226-7. PubMed ID: 9123285
    [No Abstract]   [Full Text] [Related]  

  • 23. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous administration of a neutralizing IL-1β antibody prolongs limb allograft survival.
    Hautz T; Grahammer J; Moser D; Eberhart N; Zelger B; Zelger B; Blumer MJ; Drasche A; Wolfram D; Troppmair J; Öfner D; Schneeberger S
    Am J Transplant; 2018 Aug; 18(8):2029-2042. PubMed ID: 29633557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limb transplantation in rats: immunosuppression with FK-506.
    Min Z; Jones NF
    J Hand Surg Am; 1995 Jan; 20(1):77-87. PubMed ID: 7536766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longer survival of rat limb allograft. Combined immunosuppression of FK-506 and 15-deoxyspergualin.
    Muramatsu K; Doi K; Akino T; Shigetomi M; Kawai S
    Acta Orthop Scand; 1997 Dec; 68(6):581-5. PubMed ID: 9462361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
    Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
    Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic analysis in serum of rat hind-limb allograft tolerance induced by immunosuppressive therapy with adipose-derived stem cells.
    Kuo YR; Chen CC; Goto S; Huang YT; Tsai CC; Yang MY
    Plast Reconstr Surg; 2014 Dec; 134(6):1213-1223. PubMed ID: 25255111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A long-term study of allogeneic rat hindlimb transplants immunosuppressed with RS-61443.
    Benhaim P; Anthony JP; Lin LY; McCalmont TH; Mathes SJ
    Transplantation; 1993 Oct; 56(4):911-7. PubMed ID: 8212216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synergistic effect of low-dose cyclosporine and fluocinolone acetonide on the survival of rat allogeneic skin grafts.
    Zhao XF; Alexander JW; Schroeder T; Babcock GF
    Transplantation; 1988 Oct; 46(4):490-2. PubMed ID: 3051553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Composite tissue (limb) allografts in rats. I. Dose-dependent increase in survival with cyclosporine.
    Hewitt CW; Black KS; Fraser LA; Howard EB; Martin DC; Achauer BM; Furnas DW
    Transplantation; 1985 Apr; 39(4):360-4. PubMed ID: 3872490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor leukocytes combined with delayed immunosupressive drug therapy prolong limb allograft survival.
    Matsumoto T; Kanatani T; Lanzetta M; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
    Transplant Proc; 2005 Dec; 37(10):4630-3. PubMed ID: 16387186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance of rat liver allografts induced by short-term selective immunosuppression combining monoclonal antibodies directed against CD25 and CD54 with subtherapeutic cyclosporine.
    Gassel HJ; Otto C; Gassel AM; Meyer D; Steger U; Timmermann W; Ulrichs K; Thiede A
    Transplantation; 2000 Mar; 69(6):1058-67. PubMed ID: 10762208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor modification leads to prolonged survival of limb allografts.
    Lee WP; Butler PE; Randolph MA; Yaremchuk MJ
    Plast Reconstr Surg; 2001 Oct; 108(5):1235-41. PubMed ID: 11604625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine.
    Büttemeyer R; Jones NF; Min Z; Rao U
    Plast Reconstr Surg; 1996 Jan; 97(1):139-48; discussion 149-51. PubMed ID: 8532772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitomycin-C-treated peripheral blood mononuclear cells (PBMCs) prolong allograft survival in composite tissue allotransplantation.
    Radu CA; Kiefer J; Horn D; Kleist C; Dittmar L; Sandra F; Rebel M; Ryssel H; Koellensperger E; Gebhard MM; Lehnhardt M; Germann G; Terness P
    J Surg Res; 2012 Aug; 176(2):e95-e101. PubMed ID: 22445458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapamycin, mycophenolate mofetil, methylprednisolone, and cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-based conditioning regimen to induce partial tolerance to hind limb allografts without cytoreductive conditioning.
    Pan H; Wang L; Zhang X; Zhang G; Mai H; Han Y; Guo S
    Transplant Proc; 2008 Jun; 40(5):1714-21. PubMed ID: 18589179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.